Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | INSR | P06213 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | APP | P05067 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.42 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22853482 | 0.92 | MAPT (0.47) | MAPTINSRSMN1; SMN2HTTKMT2A | |
| SCHEMBL9310865 | 0.88 | MAPT (0.51) | MAPTINSRSMN1; SMN2HTTKMT2A | |
| SCHEMBL9309167 | 0.88 | MAPT (0.51) | MAPTINSRSMN1; SMN2HTTKMT2A | |
| SCHEMBL18194201 | 0.88 | MAPT (0.41) | MAPTINSRSMN1; SMN2HTTKMT2A | |
| SCHEMBL2770177 | 0.84 | MAPT (0.46) | MAPTINSRSMN1; SMN2HTTKMT2A | |
| SCHEMBL2770179 | 0.84 | MAPT (0.46) | MAPTINSRSMN1; SMN2HTTKMT2A | |
| SCHEMBL24046701 | 0.84 | MAPT (0.50) | MAPTINSRSMN1; SMN2HTTKMT2A | |
| SCHEMBL24046663 | 0.82 | MAPT (0.67) | MAPTINSRSMN1; SMN2HTTKMT2A | |
| SCHEMBL21357710 | 0.82 | MAPT (0.44) | MAPTINSRSMN1; SMN2HTTKMT2A | |
| Bromide SCHEMBL3196350 | 0.82 | MAPT (0.44) | MAPTINSRSMN1; SMN2HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180187009-A1 | COMPOSITIONS INCLUDING A POLYTHIOL, AN UNSATURATED COMPOUND, AND A DYE AND METHODS RELATING TO SUCH COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-07-05 | — | — | US | disclosed |
| US-9772321-B2 | Benzothiazol-2-ylazo-phenyl compound as dye, compositions including the dye, and method of determining degree of cure of such compositions | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-09-26 | — | — | US | disclosed |
| US-20160319106-A1 | COMPOSITIONS INCLUDING A POLYTHIOL, AN UNSATURATED COMPOUND, AND A DYE AND METHODS RELATING TO SUCH COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY | 2016-11-03 | — | — | US | disclosed |
| US-20160041143-A1 | BENZOTHIAZOL-2-YLAZO-PHENYL COMPOUND AS DYE, COMPOSITIONS INCLUDING THE DYE, AND METHOD OF DETERMINING DEGREE OF CURE OF SUCH COMPOSITIONS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2016-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160319106-A1 | COMPOSITIONS INCLUDING A POLYTHIOL, AN UNSATURATED COMPOUND, AND A DYE AND METHODS RELATING TO SUCH COMPOSITIONS | C9, C5, PUF60 | MAPT 326/4885INSR 4021/4885SMN1; SMN2 1543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.